产品编号:B154170
产品规格:5mg
产品价格:面议
| 标准品编号: | B154170 |
| 名称: | TBDMS 4-Hydroxy Carfilzomib |
| 别名: | (S)-N-((S)-1-(((2R,4R)-1-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide |
| 分子式: | C₄₆H₇₃N₅O₈Si |
| 分子量: | 852.19 |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | (S)-N-((S)-1-(((2R,4R)-1-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide is a byproduct in the synthesis of Carfilzomib (2R,4R)-Diol (C183525), which is a derivative of Carflizomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. |
| 文献 | |